Abstract
Role of Blinatumomab in Minimal Residual Disease and Hematologic Relapsed/Refractory Adult Acute Lymphoblastic Leukemia Patients Treated over 5 Years. a Single Center Experience
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have